PubMed Health⌕ Search

Biomedical subjects

C Jansén

Publications and source records attributed to C Jansén.

12 recordsLinked to original sources
PubMed1989

Immediate decrease in antigen-presenting function and delayed enhancement of interleukin-1 production in human epidermal cells after in vivo UVB irradiation.

Human skin was irradiated in vivo with a single UVB dose (100 mJ/cm2 or 200 mJ/cm2) to examine simultaneously the antigen-presenting function and interleukin-1 (IL-1) production capacity of irradiated epidermal cells (EC). Suction blisters were produced on irradiated areas on days 0, 3 and 7 after UVB. Irradiated EC were harvested and co-cultured with autologous T lymphocytes in the presence of antigens (PPD, HSV) or mitogen (ConA). Culture supernatants were tested for IL-1 activity using the thymocyte comitogenity assay. We found that a single 200 mJ/cm2 dose of UVB caused an immediate suppression of the antigen-presenting function of EC, but no alteration in their IL-1 production capacity or surface marker expression (ATPase, CDI). PPD- and HSV-induced lymphocyte proliferation was decreased 70-80% and ConA-driven proliferation 30% when compared to non-irradiated EC. However, this suppression was restored on days 3 and 7 after UVB irradiation, this being coexistent with an increased capacity of EC to produce IL-1. It remains to be elucidated whether the immediate UVB-induced photoimmunosuppression observed in the present study is due to inhibitory mediators or impaired membrane function of EC or both.

Adult↗
PubMed1989

A clinical trial of PUVA treatment in oral lichen planus.

Seventeen patients with histologically confirmed oral lichen planus (LP) unresponsive to previous treatments were enrolled in a study on the feasibility of photochemotherapy in the treatment of oral LP. An Espe Uviolite apparatus originally designed for irradiation of light-cured dental composite fillings was used as the source of radiation. The wavelength range of the apparatus was 320-400 (UVA) nm. Two hours before irradiation, 8-methoxy-psoralen (0.6 mg/kg) was administered orally, treatments being given at intervals of 2-3 days. Subjective symptoms disappeared totally in 13 of 17 patients at a mean cumulative dose of 6.1 J/cm2. Two months after treatment with a mean total dose of 11.6 J/cm2, 12 of the 17 lesions had markedly improved. After 12-24 months of follow-up, complete clinical remission was found in 5 of the 17 patients, 7 patients were in partial remission and 5 remained only slightly improved. We conclude that PUVA treatment may be useful for treating recalcitrant oral LP but, until more extensive studies are performed, it must be considered as experimental.

Adult↗
PubMed1988

The Scandinavian multicenter photopatch study 1980-1985: final report.

At 16 different dermatology clinics in Scandinavia from 1980-1985, photopatch testing was performed on 1993 patients with suspected photodermatosis. The collective results are presented in this article. The most common cause of sun-related dermatosis was polymorphic light eruption (PLE) (38%), while secondary aggravation of pre-existing skin diseases was established in 16% of the patient group. Photocontact dermatitis (11%) and contact dermatitis (10%) were responsible for 274 and 369 positive test reactions (respectively) on photopatch testing using the SPDRG standard series. Musk ambrette and para-aminobenzoic acid were the leading photosensitizers, while perfume mixture, balsam of Peru and lichen mixture were the most frequent causes of contact sensitivity. The principal photoallergens and contact allergens in the PLE, persistent light reaction and actinic reticuloid groups are discussed, together with the problems, risks and possible mechanisms of induction of photosensitization in these patients. The incidence, causes and diagnostic and therapeutic implications of secondary sunscreen sensitivity in these groups are also addressed.

Clinical Trials as Topic↗
PubMed1987

Langerhans cell- and T-lymphocyte functions in patients with atopic dermatitis with disseminated cutaneous herpes simplex virus infection.

We studied whether Langerhans cell (LC)- and T-lymphocyte functions of atopic dermatitis (AD) patients are impaired. Our study groups consisted of 6 patients with AD with previous disseminated herpes simplex virus infection (AD + HSV), 8 patients with ordinary AD, and 5 healthy subjects. Suction blisters were performed on abdominal skin and LC isolated on the basis of their attachment to IgG-coated erythrocyte monolayers. Antigen-presenting function of purified LC was studied by measuring the proliferation of HSV-stimulated T cells. Langerhans cells were also used to stimulate T cells in autologous mixed cell reaction (AMCR). In addition, the production of epidermal cell thymocyte-activating factor (ETAF) by crude epidermal cells was measured. The HSV-induced T-cell proliferation in AD + HSV and AD patients was comparable with that of controls. The AMCR responses of patients with AD + HSV and AD were clearly diminished when compared with healthy controls. Patients with AD also produced significantly less ETAF than controls. Our results suggest that HSV antigen-presenting function of LC from patients with AD + HSV seems to be intact. Defective AMCR may reflect an abnormality in autoregulation and generation of effector cells and this together with decreased ETAF production may have pathogenetic significance in AD.

Antibodies, Viral↗
PubMed1986

Human epidermal Langerhans cells and peripheral blood monocytes. Accessory cell function, autoactivating and alloactivating capacity and ETAF/IL-1 production.

We compared the functional capacities of human epidermal Langerhans cells (LC) and peripheral blood monocytes. Epidermal sheets were obtained by a suction blister device. After enzymatic treatment LC were enriched by attaching them to IgG-located erythrocyte monolayers. On a per cell basis, LC were several times more efficient accessory cells than monocytes in augmenting nickel-and tuberculin (PPD)-induced T-cell proliferation. In mixed cell cultures LC stimulated both autologous and allogeneic T cells, whereas monocytes stimulated only allogeneic cells. In addition, LC were significantly more potent allogeneic stimulators than monocytes. Although monocytes were weaker accessory cells and allogeneic stimulators than LC, they induced higher interleukin 1 (IL-1) activities than LC-enriched or LC-depleted cells. These results indicate that there are functional differences between LC and monocytes and that antigen presentation and mediator secretion are not correlated.

Antigen-Presenting Cells↗
PubMed1985

[Phototherapy].

Explore the source record for details and available documents.

Humans↗
PubMed1979

Peroral aromatic retinoid treatment of palmoplantar pustulosis: double-blind comparison of Ro 10-9359 and placebo.

Nineteen patients with chronic, recalcitrant palmoplantar pustulosis took either placebo or aromatic retinoid ethyl ester (Ro 10-9359) during a 4-month therapeutic trial. The maximal dose of Ro 10-9359 varied between 25 and 100 mg per day, according to the individual patient's tolerance. An excellent or good therapeutic response was obtained in 6 out of 9 patients on the active medication and in 2 out of 10 patients on placebo. The difference in therapeutic response between the Ro 10-9359 group and the placebo group was statistically significant (p less than 0.05). Drying and chapping of the lips was the most common side effect of Ro 10-9359 treatment.

Adult↗